Emily Chaddock survived severe preeclampsia at 27 weeks; daughter Mia born under 2 lbs. No drugs exist to prevent it. Eli ...
AAFP CEO Shawn Martin plans to push Congress to codify ACIP’s funding and structure, limiting HHS power after RFK Jr.’s ...
RevMed's Rasonque nets $198M; Madrigal sued over Rezdiffra data; Rezera eyes $181M IPO; ANI bids $560M for Egetis; Cloudbreak ...
Caldera Therapeutics is going back to its existing partner Qyuns Therapeutics for a IL-17xTL1A bispecific antibody, while ...
Ellipsis, which uses voice AI to screen and chat with patients, bought Kouper Health, which carries out ...
Oxford spinout Alethio raises $90M Series A co-led by Sofinnova and RA Capital to take ET antibody ATX-011 into the clinic.
Kamau Therapeutics shares early data on nula-cel 2.0 for sickle cell disease; 3 patients show no pain crises or transfusion ...
Sanofi drops SAR448272, a STAT6 degrader developed with Nurix Therapeutics, after Phase 1 discontinuation. Nurix shares fell ...
CVS Health (Aetna, Caremark, Oak Street) and CVS Pharmacy. CEO David Joyner leads health unit; Prem Shah leads pharmacy.
Biotech pessimism about China more than doubles in Q3 BPSI, making it biopharma’s No. 2 worry, while Big Pharma stays net ...
J&J’s trispecific ramantamig shows 100% ORR in newly diagnosed myeloma, Tibsovo hits EFS in frontline AML, Calquence combo ...
Novo raises 2026 outlook to flat sales as the Wegovy pill outsells Lilly’s Foundayo; CFO Knudsen hands over to Galderma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results